Fort, Rafael Sebastián; Mathó, Cecilia; Geraldo, Murilo Vieira; Ottati, María Carolina; Yamashita, Alex Shimura; Saito, Kelly Cristina; Leite, Katia Ramos Moreira; Méndez, Manuel; Maedo, Noemí; Méndez, Laura; Garat, Beatriz; Kimura, Edna Teruko 
; Silveira, José Roberto Sotelo; Duhagon, María Ana
Fonte: BMC Cancer. Unidades: ICB, FM
Assuntos: METILAÇÃO DE DNA, NEOPLASIAS, NEOPLASIAS PROSTÁTICAS, METÁSTASE NEOPLÁSICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FORT, Rafael Sebastián et al. Nc886 is epigenetically repressed in prostate cancer and acts as a tumor suppressor through the inhibition of cell growth. BMC Cancer, v. 18, n. 1, p. 13 , 2018Tradução . . Disponível em: https://doi.org/10.1186/s12885-018-4049-7. Acesso em: 13 jul. 2024.APA
Fort, R. S., Mathó, C., Geraldo, M. V., Ottati, M. C., Yamashita, A. S., Saito, K. C., et al. (2018). Nc886 is epigenetically repressed in prostate cancer and acts as a tumor suppressor through the inhibition of cell growth. BMC Cancer, 18( 1), 13 . doi:10.1186/s12885-018-4049-7NLM
Fort RS, Mathó C, Geraldo MV, Ottati MC, Yamashita AS, Saito KC, Leite KRM, Méndez M, Maedo N, Méndez L, Garat B, Kimura ET, Silveira JRS, Duhagon MA. Nc886 is epigenetically repressed in prostate cancer and acts as a tumor suppressor through the inhibition of cell growth [Internet]. BMC Cancer. 2018 ; 18( 1): 13 .[citado 2024 jul. 13 ] Available from: https://doi.org/10.1186/s12885-018-4049-7Vancouver
Fort RS, Mathó C, Geraldo MV, Ottati MC, Yamashita AS, Saito KC, Leite KRM, Méndez M, Maedo N, Méndez L, Garat B, Kimura ET, Silveira JRS, Duhagon MA. Nc886 is epigenetically repressed in prostate cancer and acts as a tumor suppressor through the inhibition of cell growth [Internet]. BMC Cancer. 2018 ; 18( 1): 13 .[citado 2024 jul. 13 ] Available from: https://doi.org/10.1186/s12885-018-4049-7
